Physician profile
Deborah A Markiewicz
NPI 1780684845
$1,631.69
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $254 · 2022: $277 · 2023: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105 · Education: $26.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.87 |
| Education | $26.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $210.62 | 2019 | |
| Amgen INC. | $206.47 | 2019-2023 | Nplate, Xgeva, Vectibix |
| Astrazeneca Pharmaceuticals Lp | $198.34 | 2019-2023 | Enhertu |
| Galvanize Therapeutics, INC | $152.02 | 2022 | |
| Novocure INC. | $135.39 | 2019-2023 | Optune |
| Eisai INC. | $109.07 | 2019-2020 | |
| Puma Biotechnology, INC. | $94.83 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $85.00 | 2019-2020 | |
| Janssen Biotech, INC. | $72.92 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.05 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $48.88 | 2019-2020 | |
| Daiichi Sankyo INC. | $46.89 | 2023 | Enhertu |
| Merck Sharp & Dohme LLC | $41.90 | 2019 | |
| Stemline Therapeutics INC. | $31.80 | 2019-2020 | |
| Abbott Laboratories | $29.55 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortovia Therapeutics, INC. | $25.34 | 2019 | |
| Karyopharm Therapeutics INC. | $18.86 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.39 | 2019 | |
| Seagen INC. | $13.65 | 2019 | |
| Foundation Medicine, INC. | $12.50 | 2020 | |
| Aurobindo Pharma USA, INC. | $11.42 | 2019 | |
| Ambu INC. | $9.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Markiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.